Jansen, Mark http://orcid.org/0000-0002-0896-4440
Schmidt, A. F.
Jans, J. J. M.
Christiaans, I.
van der Crabben, S. N.
Hoedemaekers, Y. M.
Dooijes, D.
Jongbloed, J. D. H.
Boven, L. G.
Lekanne Deprez, R. H.
Wilde, A. A. M.
van der Velden, J.
de Boer, R. A.
van Tintelen, J. P.
Asselbergs, F. W.
Baas, A. F.
Funding for this research was provided by:
Hartstichting (CVON2014-40, 2020B005 DoubleDose, CVON2015-12 e-Detect, Dekker 2015T041)
UCLH Biomedical Research Centre
British Heart Foundation (PG/18/5033837, PG/22/10989, Accelerator AA/18/6/34223)
Article History
Received: 30 November 2022
Accepted: 10 May 2023
First Online: 6 June 2023
Declarations
:
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. This study was approved by the institutional review board of the UMC Utrecht. Informed consent was obtained from all patients for being included in the study. No animal studies were carried out by the authors for this article.
: No conflicts of interest relevant to this manuscript.